Chu et al. found that SRGN upregulated the CD44 receptor in an autocrine manner to maintain self-renewal in nasopharyngeal carcinoma cells by reciprocally activating the mitogen activated kinase (MAPK)/β-catenin axis (Chu et al., 2016). This evidence concerns the gene SRGN and nasopharyngeal carcinoma.